APA

Farrell A. T., Panepinto J., Desai A. A., Kassim A. A., Lebensburger J., Walters M. C., Bauer D. E., Blaylark R. M., DiMichele D. M., Gladwin M. T., Green N. S., Hassell K., Kato G. J., Klings E. S., Kohn D. B., Krishnamurti L., Little J., Makani J., Malik P., McGann P. T., Minniti C., Morris C. R., Odame I., Oneal P. A., Setse R., Sharma P. & Shenoy S. (20200922). End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings. : Blood advances.

Chicago

Farrell Ann T, Panepinto Julie, Desai Ankit A, Kassim Adetola A, Lebensburger Jeffrey, Walters Mark C, Bauer Daniel E, Blaylark Rae M, DiMichele Donna M, Gladwin Mark T, Green Nancy S, Hassell Kathryn, Kato Gregory J, Klings Elizabeth S, Kohn Donald B, Krishnamurti Lakshmanan, Little Jane, Makani Julie, Malik Punam, McGann Patrick T, Minniti Caterina, Morris Claudia R, Odame Isaac, Oneal Patricia Ann, Setse Rosanna, Sharma Poornima and Shenoy Shalini. 20200922. End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings. : Blood advances.

Harvard

Farrell A. T., Panepinto J., Desai A. A., Kassim A. A., Lebensburger J., Walters M. C., Bauer D. E., Blaylark R. M., DiMichele D. M., Gladwin M. T., Green N. S., Hassell K., Kato G. J., Klings E. S., Kohn D. B., Krishnamurti L., Little J., Makani J., Malik P., McGann P. T., Minniti C., Morris C. R., Odame I., Oneal P. A., Setse R., Sharma P. and Shenoy S. (20200922). End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings. : Blood advances.

MLA

Farrell Ann T, Panepinto Julie, Desai Ankit A, Kassim Adetola A, Lebensburger Jeffrey, Walters Mark C, Bauer Daniel E, Blaylark Rae M, DiMichele Donna M, Gladwin Mark T, Green Nancy S, Hassell Kathryn, Kato Gregory J, Klings Elizabeth S, Kohn Donald B, Krishnamurti Lakshmanan, Little Jane, Makani Julie, Malik Punam, McGann Patrick T, Minniti Caterina, Morris Claudia R, Odame Isaac, Oneal Patricia Ann, Setse Rosanna, Sharma Poornima and Shenoy Shalini. End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings. : Blood advances. 20200922.